Figure 1
Figure 1. Survival of patients after discontinuation of ibrutinib. Patients survived for a median of 3.1 months after discontinuation of ibrutinib (n = 33).

Survival of patients after discontinuation of ibrutinib. Patients survived for a median of 3.1 months after discontinuation of ibrutinib (n = 33).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal